CalciMedica, Historical Balance Sheet
| CALC Stock | 2.76 0.01 0.36% |
Trend analysis of CalciMedica, Common Stock balance sheet accounts such as Other Current Liab of 3.1 M, Total Current Liabilities of 4.9 M or Total Stockholder Equity of 7.7 M provides information on CalciMedica, Common's total assets, liabilities, and equity, which is the actual value of CalciMedica, Common Stock to its prevalent stockholders. By breaking down trends over time using CalciMedica, Common balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining CalciMedica, Common Stock latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether CalciMedica, Common Stock is a good buy for the upcoming year.
CalciMedica, Common Inventory |
|
CalciMedica, |
About CalciMedica, Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of CalciMedica, Common Stock at a specified time, usually calculated after every quarter, six months, or one year. CalciMedica, Common Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of CalciMedica, Common and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which CalciMedica, currently owns. An asset can also be divided into two categories, current and non-current.
CalciMedica, Common Balance Sheet Chart
Add Fundamental
Total Assets
Total assets refers to the total amount of CalciMedica, Common assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in CalciMedica, Common Stock books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Current Liabilities
Total Current Liabilities is an item on CalciMedica, Common balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of CalciMedica, Common Stock are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Total Stockholder Equity
The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.Most accounts from CalciMedica, Common's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into CalciMedica, Common Stock current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CalciMedica, Common Stock. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. At present, CalciMedica, Common's Total Current Liabilities is projected to decrease significantly based on the last few years of reporting. The current year's Accounts Payable is expected to grow to about 1.9 M, whereas Total Assets are forecasted to decline to about 11.6 M.
| 2021 | 2022 | 2023 | 2024 (projected) | Other Current Liabilities | 3.5M | 1.7M | 2.5M | 3.1M | Total Assets | 69.1M | 39.7M | 12.2M | 11.6M |
CalciMedica, Common balance sheet Correlations
Click cells to compare fundamentals
CalciMedica, Common Account Relationship Matchups
High Positive Relationship
High Negative Relationship
CalciMedica, Common balance sheet Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 40.7M | 101.8M | 69.1M | 39.7M | 12.2M | 11.6M | |
| Other Current Liab | 7.6M | 4.5M | 3.5M | 1.7M | 2.5M | 3.1M | |
| Total Current Liabilities | 12.3M | 7.0M | 4.1M | 3.7M | 4.0M | 4.9M | |
| Total Stockholder Equity | 28.4M | 94.8M | 65.0M | 36.0M | 8.2M | 7.7M | |
| Property Plant And Equipment Net | 2.0M | 1.9M | 2.0M | 195K | 167K | 158.7K | |
| Net Debt | (15.9M) | (33.4M) | (13.4M) | (17.1M) | (5.5M) | (5.8M) | |
| Retained Earnings | (105.8M) | (133.4M) | (169.2M) | (204.8M) | (146.1M) | (153.4M) | |
| Accounts Payable | 4.6M | 2.5M | 527K | 2.9M | 1.4M | 1.9M | |
| Cash | 15.9M | 33.4M | 13.4M | 17.3M | 5.5M | 5.3M | |
| Non Current Assets Total | 4.4M | 2.6M | 2.0M | 1.6M | 580K | 551K | |
| Non Currrent Assets Other | 2.4M | 580K | 29K | 1.4M | 413K | 392.4K | |
| Cash And Short Term Investments | 36.0M | 95.0M | 63.7M | 39.1M | 11.2M | 10.7M | |
| Common Stock Shares Outstanding | 1.0M | 472.7K | 1.5M | 1.5M | 4.5M | 4.7M | |
| Liabilities And Stockholders Equity | 40.7M | 101.8M | 69.1M | 39.7M | 12.2M | 11.6M | |
| Other Current Assets | 315K | 4.2M | 3.4M | 1.0M | 367K | 348.7K | |
| Other Stockholder Equity | 2.9M | 228.2M | 234.2M | 40.4M | 154.2M | 121.4M | |
| Total Liab | 12.3M | 7.0M | 4.1M | 3.7M | 4.0M | 4.9M | |
| Total Current Assets | 36.3M | 99.2M | 67.1M | 39.7M | 11.6M | 11.0M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether CalciMedica, Common Stock offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of CalciMedica, Common's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Calcimedica, Common Stock Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Calcimedica, Common Stock Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CalciMedica, Common Stock. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CalciMedica, Common. If investors know CalciMedica, will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CalciMedica, Common listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.11) | Return On Assets (0.65) | Return On Equity (0.84) |
The market value of CalciMedica, Common Stock is measured differently than its book value, which is the value of CalciMedica, that is recorded on the company's balance sheet. Investors also form their own opinion of CalciMedica, Common's value that differs from its market value or its book value, called intrinsic value, which is CalciMedica, Common's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CalciMedica, Common's market value can be influenced by many factors that don't directly affect CalciMedica, Common's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CalciMedica, Common's value and its price as these two are different measures arrived at by different means. Investors typically determine if CalciMedica, Common is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CalciMedica, Common's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.